IC
KOD icon

Ikarian Capital’s Kodiak Sciences KOD Stock Holding History

Ikarian Capital’s Portfolio KOD Stock Details KOD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.3M Sell
1,059,730
-206,065
-16% -$8.02M 4.45% 4
2026
Q1 		$48.3M Buy
1,265,795
+546,008
+76% +$14.1M 3.92% 6
2025
Q4 		$20.1M Buy
719,787
+305,946
+74% +$6.27M 1.57% 14
2025
Q3 		$6.77M Sell
413,841
-185,693
-31% -$1.6M 0.68% 35
2025
Q2 		$2.24M Sell
599,534
-50,000
-8% -$177K 0.43% 64
2025
Q1 		$1.82M Buy
649,534
+73,368
+13% +$399K 0.22% 72
2024
Q4 		$5.73M Buy
576,166
+99,580
+21% +$572K 0.78% 34
2024
Q3 		$1.24M Hold
476,586
– – 0.17% 89
2024
Q2 		$1.12M Hold
476,586
– – 0.2% 73
2024
Q1 		$2.51M Buy
476,586
+63,705
+15% +$312K 0.27% 78
2023
Q4 		$1.26M Buy
412,881
+100,000
+32% +$222K 0.12% 93
2023
Q3 		$563K Buy
312,881
+250,354
+400% +$883K 0.07% 111
2023
Q2 		$431K Sell
62,527
-100,000
-62% -$612K 0.07% 101
2023
Q1 		$1.01M Buy
+162,527
New +$1.14M 0.23% 78
2022
Q2 		– Sell
-68,100
Closed -$526K – 171
2022
Q1 		$526K Buy
+68,100
New +$2.66M 0.07% 136

Other funds holding KOD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Ikarian Capital's KOD Position: Q2 2026 in Review

Ikarian Capital reduced its Kodiak Sciences (KOD) stake by 16% in Q2 2026, selling an estimated $8.02M and leaving 1,059,730 shares worth $41.3M. The position accounts for 4.45% of the portfolio, ranked #4.

Ikarian Capital first reported a position in KOD in Q1 2022 and has held it in 15 quarters since. The position peaked at $48.3M in Q1 2026. 200 funds tracked by Wall St. Rank hold KOD as of Q2 2026.

  • Ikarian Capital held 1,059,730 shares of Kodiak Sciences worth $41.3M as of Q2 2026.
  • Ikarian Capital sold 206,065 Kodiak Sciences shares in Q2 2026, an estimated $8.02M.
  • Kodiak Sciences made up 4.45% of Ikarian Capital's portfolio in Q2 2026, its #4 holding.
  • Ikarian Capital first reported a position in Kodiak Sciences in Q1 2022 and has held it in 15 quarters since.
  • Ikarian Capital's Kodiak Sciences position peaked at $48.3M in Q1 2026.
  • 200 funds tracked by Wall St. Rank held Kodiak Sciences as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.